| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.7 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |